ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Session » Health Services Research - Poster II

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

Abstract Number: 1220
Comparison of Healthcare Utilization of Patients with Rheumatoid Arthritis Who Are Anti-Cyclic Citrullinated Peptide Antibody Positive Versus Negative
Abstract Number: 1221
Environmental Scan of Rheumatoid Arthritis Patient Registries Around the World: An Omeract Initiative
Abstract Number: 1222
A Systematic Review of Consumer Perceived Health Service Needs Related to Osteoarthritis
Abstract Number: 1223
The Cost of Confronting Osteoporosis:Cost Study of a Fracture Liaison Service
Abstract Number: 1224
Healthcare and Research Priorities of Adolescents and Young Adults with Systemic Lupus Erythematosus: A Mixed-Methods Study
Abstract Number: 1225
Serum Uric Acid Testing Practices over Five Years Among Incident Gout Cases
Abstract Number: 1226
Evaluation of the Association Between C-Reactive Protein and Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: Analysis of Two Clinical Practice Data Sets
Abstract Number: 1227
Clinician-Led Development of a Standardised Term Set for Rheumatic and Musculoskeletal Disorders Allows Easy Creation of Large-Scale ICD-10 and Snomed CT Mapped Datasets from Routinely Collected Clinical Data
Abstract Number: 1228
Prescribing for Children with Rheumatologic Disease: Differences Between Pediatric and Adult Rheumatologists
Abstract Number: 1229
Stakeholder Needs Assessment for a New Model of Care for Pediatric Rheumatology in Ontario
Abstract Number: 1230
Allopurinol Use and the Risk of Stroke in the Elderly
Abstract Number: 1231
Impact of Comorbidity on Health-Related Quality of Life and Healthcare Expenditure in Patients with Rheumatoid Arthritis
Abstract Number: 1232
Interdisciplinary Osteoporosis Clinical Working Group and Fracture Liaison Service at Loma Linda University Medical Center (LLUMC): Laying the Groundwork
Abstract Number: 1233
A Descriptive Analysis of Real-World Treatment Patterns of Innovator Infliximab (Remicade) and Biosimilar Infliximab in a Treatment NaïVe Turkish Rheumatologic Disease Population
Abstract Number: 1234
Does SLE Care in a Lupus Clinic Result in Higher Quality Scores Than in General Rheumatology Clinics?
Abstract Number: 1235
Healthcare Utilization and Multimorbidities Among Adult Patients with Juvenile Idiopathic Arthritis
Abstract Number: 1236
Rheumatoid Arthritis-Interstitial Lung Disease in the United States: Prevalence, Incidence, and Healthcare Costs
Abstract Number: 1237
The Economic Burden of Dermatomyositis and Polymyositis in the US
Abstract Number: 1238
Assessment of Mortality and Healthcare Costs Associated with Systemic Sclerosis with and without Lung Involvement
Abstract Number: 1239
Optimizing Screening for Psoriatic Arthritis through a Shortened Psoriatic Arthritis Screening and Evaluation-2 (PASE-2) Tool
Abstract Number: 1240
A Minority of Patients Utilize Most of Healthcare Resources in Rheumatoid Arthritis, Psoriatic Arthritis, Juvenile Idiopathic Arthritis, and Axial Spondyloarthritis
Abstract Number: 1241
Understanding Lupus Patients’ Ability to Work with Numbers
Abstract Number: 1242
Rate of Hospitalization for Heart Failure Is Lower in Patients with Controlled Gout Versus Uncontrolled Gout
Abstract Number: 1243
Validity of the Short Form 6D Utility Measure in Early Axial Spondyloarthritis
Abstract Number: 1244
Establishing a Case Report Form (CRF) for Systemic Autoimmune Diseases Studies
Abstract Number: 1245
Comparison of Secukinumab Vs Adalimumab in a Cost per Responder Analysis Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Psoriatic Arthritis at 48 Weeks from the US Perspective
Abstract Number: 1246
Causes and Predictors of Early Readmission in Systemic Lupus Erythematosus

« View all sessions from this meeting

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences